IP Master Class: Obtaining Government Approval of ANDA Litigation Settlements

September 12, 2006
Pharmaceutical patent litigation is becoming increasingly difficult to settle, because government approval of settlements between the litigants is increasingly difficult to obtain.  Assuming that litigants want to settle, what are the terms and the process for getting government approval, especially FTC approval?  A former General Counsel of the FTC, now representing pioneering pharmaceutical companies, offers practical insights on how to navigate this very challenging process.